Annual Gross Profit
$317.60 M
-$65.40 M-17.08%
31 December 2023
Summary:
Emergent BioSolutions annual gross profit is currently $317.60 million, with the most recent change of -$65.40 million (-17.08%) on 31 December 2023. During the last 3 years, it has fallen by -$607.60 million (-65.67%). EBS annual gross profit is now -65.67% below its all-time high of $925.20 million, reached on 31 December 2020.EBS Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$161.20 M
+$209.20 M+435.83%
30 September 2024
Summary:
Emergent BioSolutions quarterly gross profit is currently $161.20 million, with the most recent change of +$209.20 million (+435.83%) on 30 September 2024. Over the past year, it has increased by +$74.00 million (+84.86%). EBS quarterly gross profit is now -62.51% below its all-time high of $430.00 million, reached on 31 December 2021.EBS Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$345.80 M
+$74.00 M+27.23%
30 September 2024
Summary:
Emergent BioSolutions TTM gross profit is currently $345.80 million, with the most recent change of +$74.00 million (+27.23%) on 30 September 2024. Over the past year, it has increased by +$10.40 million (+3.10%). EBS TTM gross profit is now -67.21% below its all-time high of $1.05 billion, reached on 31 March 2021.EBS TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.1% | +84.9% | +3.1% |
| 3 y3 years | -65.7% | +70.4% | -58.9% |
| 5 y5 years | -17.1% | -4.2% | -27.6% |
EBS Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.7% | at low | -62.5% | +435.8% | -61.2% | +39.2% |
| 5 y | 5 years | -65.7% | at low | -62.5% | +435.8% | -67.2% | +39.2% |
| alltime | all time | -65.7% | +494.9% | -62.5% | +435.8% | -67.2% | +890.9% |
Emergent BioSolutions Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $161.20 M(-435.8%) | $345.80 M(+27.2%) |
| June 2024 | - | -$48.00 M(-132.5%) | $271.80 M(-41.0%) |
| Mar 2024 | - | $147.80 M(+74.3%) | $460.50 M(+45.0%) |
| Dec 2023 | $317.60 M(-17.1%) | $84.80 M(-2.8%) | $317.60 M(-5.3%) |
| Sept 2023 | - | $87.20 M(-38.0%) | $335.40 M(+3.7%) |
| June 2023 | - | $140.70 M(+2771.4%) | $323.50 M(+30.2%) |
| Mar 2023 | - | $4.90 M(-95.2%) | $248.40 M(-35.6%) |
| Dec 2022 | $383.00 M(-57.0%) | $102.60 M(+36.3%) | $385.50 M(-45.9%) |
| Sept 2022 | - | $75.30 M(+14.8%) | $712.90 M(-2.6%) |
| June 2022 | - | $65.60 M(-53.8%) | $732.20 M(-9.7%) |
| Mar 2022 | - | $142.00 M(-67.0%) | $810.90 M(-9.0%) |
| Dec 2021 | $891.30 M(-3.7%) | $430.00 M(+354.5%) | $891.30 M(+5.9%) |
| Sept 2021 | - | $94.60 M(-34.4%) | $841.90 M(-12.1%) |
| June 2021 | - | $144.30 M(-35.1%) | $957.60 M(-9.2%) |
| Mar 2021 | - | $222.40 M(-41.6%) | $1.05 B(+14.0%) |
| Dec 2020 | $925.20 M(+68.2%) | $380.60 M(+81.0%) | $925.20 M(+23.7%) |
| Sept 2020 | - | $210.30 M(-12.8%) | $748.00 M(+6.0%) |
| June 2020 | - | $241.30 M(+159.5%) | $705.90 M(+24.7%) |
| Mar 2020 | - | $93.00 M(-54.3%) | $566.00 M(+2.9%) |
| Dec 2019 | $550.00 M(+43.6%) | $203.40 M(+20.9%) | $550.10 M(+15.2%) |
| Sept 2019 | - | $168.20 M(+65.9%) | $477.50 M(+20.8%) |
| June 2019 | - | $101.40 M(+31.5%) | $395.40 M(-4.1%) |
| Mar 2019 | - | $77.10 M(-41.1%) | $412.40 M(+7.7%) |
| Dec 2018 | $383.10 M(+26.6%) | $130.80 M(+51.9%) | $382.90 M(+4.1%) |
| Sept 2018 | - | $86.10 M(-27.3%) | $367.67 M(-0.7%) |
| June 2018 | - | $118.40 M(+148.7%) | $370.28 M(+24.7%) |
| Mar 2018 | - | $47.60 M(-58.8%) | $297.02 M(-1.9%) |
| Dec 2017 | $302.70 M(+38.2%) | $115.57 M(+30.3%) | $302.70 M(+17.3%) |
| Sept 2017 | - | $88.70 M(+96.5%) | $258.01 M(+7.0%) |
| June 2017 | - | $45.15 M(-15.3%) | $241.16 M(+7.2%) |
| Mar 2017 | - | $53.27 M(-24.8%) | $225.03 M(+2.7%) |
| Dec 2016 | $219.10 M(-17.1%) | $70.89 M(-1.3%) | $219.10 M(-11.9%) |
| Sept 2016 | - | $71.85 M(+147.6%) | $248.74 M(-8.0%) |
| June 2016 | - | $29.02 M(-38.7%) | $270.50 M(-11.3%) |
| Mar 2016 | - | $47.34 M(-52.9%) | $305.10 M(+13.2%) |
| Dec 2015 | $264.45 M | $100.53 M(+7.4%) | $269.54 M(+9.6%) |
| Sept 2015 | - | $93.61 M(+47.2%) | $245.93 M(+15.0%) |
| June 2015 | - | $63.62 M(+439.8%) | $213.78 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $11.79 M(-84.7%) | $203.12 M(-3.7%) |
| Dec 2014 | $210.83 M(+7.7%) | $76.91 M(+25.1%) | $210.83 M(+5.3%) |
| Sept 2014 | - | $61.47 M(+16.1%) | $200.16 M(+2.7%) |
| June 2014 | - | $52.95 M(+171.6%) | $194.93 M(+2.3%) |
| Mar 2014 | - | $19.50 M(-70.6%) | $190.63 M(-2.6%) |
| Dec 2013 | $195.79 M(+15.3%) | $66.25 M(+17.8%) | $195.79 M(+3.7%) |
| Sept 2013 | - | $56.23 M(+15.6%) | $188.75 M(+7.1%) |
| June 2013 | - | $48.65 M(+97.3%) | $176.29 M(+5.2%) |
| Mar 2013 | - | $24.66 M(-58.3%) | $167.62 M(-1.3%) |
| Dec 2012 | $169.80 M(+6.0%) | $59.20 M(+35.2%) | $169.80 M(+27.4%) |
| Sept 2012 | - | $43.78 M(+9.5%) | $133.25 M(-3.1%) |
| June 2012 | - | $39.98 M(+48.9%) | $137.52 M(-18.9%) |
| Mar 2012 | - | $26.85 M(+18.6%) | $169.62 M(+5.9%) |
| Dec 2011 | $160.24 M(-21.6%) | $22.64 M(-52.9%) | $160.24 M(-15.2%) |
| Sept 2011 | - | $48.06 M(-33.3%) | $189.05 M(-7.1%) |
| June 2011 | - | $72.07 M(+312.7%) | $203.45 M(+11.5%) |
| Mar 2011 | - | $17.46 M(-66.1%) | $182.44 M(-10.7%) |
| Dec 2010 | $204.27 M(+8.4%) | $51.46 M(-17.6%) | $204.27 M(+4.8%) |
| Sept 2010 | - | $62.45 M(+22.3%) | $194.83 M(+16.7%) |
| June 2010 | - | $51.06 M(+30.0%) | $166.96 M(-6.5%) |
| Mar 2010 | - | $39.29 M(-6.5%) | $178.66 M(-5.2%) |
| Dec 2009 | $188.52 M(+30.5%) | $42.02 M(+21.5%) | $188.52 M(+7.5%) |
| Sept 2009 | - | $34.59 M(-44.9%) | $175.38 M(-6.1%) |
| June 2009 | - | $62.76 M(+27.7%) | $186.87 M(+17.6%) |
| Mar 2009 | - | $49.15 M(+70.2%) | $158.91 M(+10.0%) |
| Dec 2008 | $144.47 M(+1.3%) | $28.88 M(-37.3%) | $144.47 M(-23.0%) |
| Sept 2008 | - | $46.08 M(+32.4%) | $187.69 M(+8.0%) |
| June 2008 | - | $34.80 M(+0.3%) | $173.84 M(+11.2%) |
| Mar 2008 | - | $34.71 M(-51.9%) | $156.38 M(+9.7%) |
| Dec 2007 | $142.61 M(+10.9%) | $72.09 M(+123.6%) | $142.61 M(-1.6%) |
| Sept 2007 | - | $32.24 M(+85.9%) | $144.92 M(-1.8%) |
| June 2007 | - | $17.34 M(-17.1%) | $147.58 M(+13.3%) |
| Mar 2007 | - | $20.93 M(-71.9%) | $130.24 M(+19.1%) |
| Dec 2006 | $128.61 M(+29.8%) | $74.41 M(+113.2%) | $109.31 M(+213.2%) |
| Sept 2006 | - | $34.90 M | $34.90 M |
| Dec 2005 | $99.08 M(+85.6%) | - | - |
| Dec 2004 | $53.39 M(-1.1%) | - | - |
| Dec 2002 | $53.97 M | - | - |
FAQ
- What is Emergent BioSolutions annual gross profit?
- What is the all time high annual gross profit for Emergent BioSolutions?
- What is Emergent BioSolutions annual gross profit year-on-year change?
- What is Emergent BioSolutions quarterly gross profit?
- What is the all time high quarterly gross profit for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly gross profit year-on-year change?
- What is Emergent BioSolutions TTM gross profit?
- What is the all time high TTM gross profit for Emergent BioSolutions?
- What is Emergent BioSolutions TTM gross profit year-on-year change?
What is Emergent BioSolutions annual gross profit?
The current annual gross profit of EBS is $317.60 M
What is the all time high annual gross profit for Emergent BioSolutions?
Emergent BioSolutions all-time high annual gross profit is $925.20 M
What is Emergent BioSolutions annual gross profit year-on-year change?
Over the past year, EBS annual gross profit has changed by -$65.40 M (-17.08%)
What is Emergent BioSolutions quarterly gross profit?
The current quarterly gross profit of EBS is $161.20 M
What is the all time high quarterly gross profit for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly gross profit is $430.00 M
What is Emergent BioSolutions quarterly gross profit year-on-year change?
Over the past year, EBS quarterly gross profit has changed by +$74.00 M (+84.86%)
What is Emergent BioSolutions TTM gross profit?
The current TTM gross profit of EBS is $345.80 M
What is the all time high TTM gross profit for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM gross profit is $1.05 B
What is Emergent BioSolutions TTM gross profit year-on-year change?
Over the past year, EBS TTM gross profit has changed by +$10.40 M (+3.10%)